HIV Treatment and Medical Care

Complera (Rilpivirine/Tenofovir Disoproxil Fumarate/FTC)

The Latest

An Overview of Complera (Rilpivirine/Tenofovir/Emtricitabine) Img

An Overview of Complera (Rilpivirine/Tenofovir/Emtricitabine)

Looking for a breakdown of the most important info to know about Complera, the newest once-daily, fixed-dose combination drug approved in the U.S. for first-line treatment? The government resource AIDSinfo has compiled this fact sheet that explains h...

By AIDSinfo
One-a-Day HIV Treatments: How Do They Compare? (Infographic) Img

One-a-Day HIV Treatments: How Do They Compare? (Infographic)

Just one pill a day to control HIV? This once-fanciful idea became a reality in 2006, when Atripla was approved as the first single-tablet HIV medication regimen in the U.S. A single-tablet regimen (STR) contains meds from different drug classes and ...

Promo Image

Complera/Eviplera (Rilpivirine + Emtricitabine + Tenofovir)

What Is Complera? Who Should Take Complera? Who Should Not Take Complera? What About Drug Resistance? How Is Complera Taken? What Are the Side Effects? How Does Complera React With Other Drugs?

What Is Complera?

Complera is a tablet t...

By AIDS InfoNet
Promo Image


Brand name: Complera

Generic name: rilpivirine/emtricitabine/tenofovir, or RPV/FTC/TDF

Class: NNRTI and NRTI -- single-tablet regimen (STR)

Manufacturer: Gilead Sciences,, (800) GILEAD-5 (445-3235)

AWP: $2,195.83/month; ADAP/Public...

By Positively Aware